Ms. Chunias has extensive experience representing corporations and individuals in connection with civil and criminal government investigations and prosecutions, most notably in relation to alleged violations of the Foreign Corrupt Practices Act and the federal False Claims Act, as well as health care fraud, securities fraud, insider trading, visa fraud, and export violations.
Ms. Chunias also has extensive experience conducting internal investigations for public and private companies, audit committees, and other special board committees, including investigations into whistleblower complaints arising under the Sarbanes-Oxley Act and Dodd-Frank Act. She routinely works with clients on the development and implementation of appropriate policies and remedial actions to address compliance and internal control deficiencies identified through such investigations, and advises technology and life sciences, private equity, and other clients on global corruption risks in IPO and transactional due diligence contexts.
Among her recent matters, Ms. Chunias’s representations include:
- A global technology company in connection with False Claim Act qui tam litigation and criminal investigations by the U.S. Attorney's Office and the U.S. Department of Justice, National Security Division, relating to defense contracts and allegations of visa fraud, contract fraud, and ITAR violations.
- Research misconduct investigations and related litigation on behalf of universities and research institutions. Such representations have included the successful dismissal of a federal lawsuit challenging an institutional research misconduct investigation on behalf of Harvard Medical School;
- The Special Board Committee of a public medical technology company in relation to an internal investigation of whistleblower allegations of FCPA violations and bribery relating to import of company products into Russia and Eastern Europe;
- A U.S.-based global manufacturer of scientific instruments and medical devices in connection with investigations by the SEC, DOJ and Hong Kong Independent Commission Against Corruption into alleged bribery and corruption violations at several of the Company's China subsidiaries, including relating to the use of third-party intermediaries in connection with contracts with state-owned entities;
- Various technology and life sciences companies and private equity portfolio companies in post-closing disputes, government inquiries, and internal investigations;
- A financial consulting firm in False Claim Act and class action litigation arising out of “pay-to-play” allegations relating to the New Mexico State pension system;
- The former CEO of a pharmaceutical and medical device company in connection with a federal indictment relating to the company's sale of allegedly unapproved and adulterated drugs, successfully arguing for a significant downward departure following the entry of a guilty plea;
- A private healthcare consulting firm in connection with multiple FCA qui tam whistleblower suits arising out of allegations that the company assisted hospitals seeking and receiving inflated Medicare and Medicaid reimbursements;
- A national pension consulting firm in connection with claims relating to the Madoff Ponzi scheme; and
- The former president of a publicly-traded home healthcare company in connection with an investigation by the DOJ, successfully arguing for a significant downward departure following entry of a guilty plea on charges of money laundering and filing false tax returns.
In 2016, Ms. Chunias was appointed by Massachusetts Governor Charlie Baker to the State Ballot Law Commission.
Ms. Chunias has served on the Board of the Women's Bar Foundation, on the BBA's Individual Rights Responsibilities Section Steering Committee, and as a pro bono Bar Advocate, handling dozens of court appointments in the Criminal Division of the Boston Municipal Court.
Prior to joining Goodwin in 2005, Ms. Chunias was a lecturer at Harvard Law School. Before that, she was an associate in the Litigation Practice Group at Testa, Hurwitz & Thibeault, LLP in Boston.